| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/21/2010 | WO2010008010A1 Hcv/gbv-b chimeric virus |
| 01/21/2010 | WO2010007724A1 Peptide capable of binding to epcam |
| 01/21/2010 | WO2010007723A1 Peptide capable of binding to ceramic material |
| 01/21/2010 | WO2010007701A1 Therapeutic agent and test agent for disease with myocardial necrosis |
| 01/21/2010 | WO2010007622A2 Long-acting interferons and derivatives thereof and methods thereof |
| 01/21/2010 | WO2010007593A1 Methods of long-term culture of eukaryotic cells and uses thereof |
| 01/21/2010 | WO2010007551A2 Method for the production of tenocytes in vitro from mesenchymal stem cells |
| 01/21/2010 | WO2010007388A1 Bsm1 protein expression system |
| 01/21/2010 | WO2010007372A1 Transgenic rodent expressing truncated disc1 |
| 01/21/2010 | WO2010007144A2 New mutated netrin 4 proteins, fragments thereof and their uses as drugs |
| 01/21/2010 | WO2010007035A1 Plants having enhanced yield-related traits and a method for making the same |
| 01/21/2010 | WO2010006804A1 Method to obtain transgenic plants resistant to phytopathogen attack based on rna interference (rnai) |
| 01/21/2010 | WO2010006772A2 Use of cd95 inhibitors for the treatment of inflammatory disorders |
| 01/21/2010 | WO2010006732A2 Brassica plant comprising a mutant indehiscent allelle |
| 01/21/2010 | WO2010006720A1 Anti-amyloid immunogenic compositions, methods and uses |
| 01/21/2010 | WO2010006508A1 INTEGRIN PEPTIDE, ANTI-CD 18 βA ANTIBODY FOR TREATMENT OF ENDOTOXIN-MEDIATED PRO-INFLAMMATORY RESPONSES AND THE USE |
| 01/21/2010 | WO2010006452A1 New influenza virus immunizing epitope |
| 01/21/2010 | WO2010006447A1 Chimeric respiratory syncytial virus polypeptide antigens |
| 01/21/2010 | WO2010006377A1 Therapeutic agents |
| 01/21/2010 | WO2009145489A3 Cell-permeable endostatin recombinant protein, a polynucleotide coated with the same, and an anti-cancer preparation containing the same as an active component |
| 01/21/2010 | WO2009137605A3 AFFINITY MATURED CRIg VARIANTS |
| 01/21/2010 | WO2009135810A8 Plants having enhanced yield-related traits and a method for making the same |
| 01/21/2010 | WO2009132656A3 Crystal structure of human sortilin and uses thereof for identifying ligands to sortilin |
| 01/21/2010 | WO2009130612A3 Prion epitopes and methods of use thereof |
| 01/21/2010 | WO2009128056A3 A method for screening compounds comprising the use of picornavirus protease 2a |
| 01/21/2010 | WO2009126292A3 Biologically active peptidomimetic macrocycles |
| 01/21/2010 | WO2009112583A3 Protease-stabilized insulin analogues |
| 01/21/2010 | WO2009102421A3 Targeted therapeutics based on engineered proteins that bind egfr |
| 01/21/2010 | WO2009100040A3 Cell lines expressing gaba receptor and methods using them |
| 01/21/2010 | WO2009094610A9 Novel cell lines expressing enac and methods using them |
| 01/21/2010 | WO2009090056A3 Purification of non-glycosylated proteins |
| 01/21/2010 | WO2009009186A3 Receptors useful for gas phase chemical sensing |
| 01/21/2010 | WO2005074521A9 C-TERMINAL p53 PALINDROMIC PEPTIDE THAT INDUCES APOPTOSIS OF CELLS WITH ABERRANT p53 AND USES THEREOF |
| 01/21/2010 | WO2004056961A9 Methods of identifying compounds that modulate protein activity |
| 01/21/2010 | WO2004041170A9 Compositions and methods for the treatment of immune related diseases |
| 01/21/2010 | WO2004039333A9 ANTIGENIC gp 100 COMPOUNDS FOR THERAPY AND DIAGNOSIS AND METHODS FOR USING SAME |
| 01/21/2010 | WO2004024097A9 Compositions and methods for the treatment of immune related diseases |
| 01/21/2010 | WO2003057859A9 Genes for altering mitochondrial function and for hybrid seed production |
| 01/21/2010 | WO2003006624A9 47619 and 47621, human ion channels, and uses thereof |
| 01/21/2010 | WO2003006609A9 Human cytokine receptor |
| 01/21/2010 | WO2002078642A9 Differentially-expressed and up-regulated polynucleotides and polypeptides in breast cancer |
| 01/21/2010 | US20100017919 Rice Gene, GS3, Exerting Primary Control Over Grain Length and Grain Weight |
| 01/21/2010 | US20100017894 Mutants of Human App and Their Use for the Production of Transgenice Animals |
| 01/21/2010 | US20100016653 Quantitative Trait Loci and Somatostatin |
| 01/21/2010 | US20100016572 Derived from the N-terminal domain of the serine-repeat antigen produced by the malaria parasite, Plasmodium falciparum; can be produced in Escherichia coli on a large scale by deleting all or part of polymerized serines of the 47 kd serine-repeat region; inhibit fever and cerebral malaria |
| 01/21/2010 | US20100016565 Identification and characterization of an anthocyanin mutant (ant1) in tomato |
| 01/21/2010 | US20100016562 Reducing the immunogenicity of fusion proteins |
| 01/21/2010 | US20100016561 N-Acetylglucosaminyltransferase III Expression in Lower Eukaryotes |
| 01/21/2010 | US20100016558 Cloning and recombinant production of receptor(s) of the activin/tgf-beta superfamily |
| 01/21/2010 | US20100016555 N-Acetylglucosaminyltransferase III Expression in Lower Eukaryotes |
| 01/21/2010 | US20100016554 Method and system for corn fractionation |
| 01/21/2010 | US20100016553 Internalization |
| 01/21/2010 | US20100016552 Novel hemopoietic receptor protein, NR10 |
| 01/21/2010 | US20100016549 Peyer's patch and/or m-cell targeting ligands |
| 01/21/2010 | US20100016547 Glycosilated Peptide and Medicine Comprising It as an Effective Ingredient |
| 01/21/2010 | US20100016431 Genes encoding a novel type of lysophophatidylcholine acyltransferases and their use to increase triacylglycerol production and/or modify fatty acid composition |
| 01/21/2010 | US20100016415 Proteins Expressed by Mycobacterium Tuberculosis and not by BCG and their use as Diagnostic Reagents and Vaccines |
| 01/21/2010 | US20100016364 Method of predictive determination of responsiveness to pharmacological intervention |
| 01/21/2010 | US20100016242 Myosin light chain kinase inhibitors and methods of use |
| 01/21/2010 | US20100016241 Methods and compositions for inhibiting c-met dimerization and activation |
| 01/21/2010 | US20100016234 Signal peptides, nucleic acid molecules and methods for treatment of caries |
| 01/21/2010 | US20100016228 Truncated bard1 protein, and its diagnostic and therapeutic uses |
| 01/21/2010 | US20100016227 Ligand/lytic peptide compositions and methods of use |
| 01/21/2010 | US20100016225 CONJUGATES COMPRISED OF POLYMER AND HIV gp-41-DERIVED PEPTIDES AND THEIR USE IN THERAPY |
| 01/21/2010 | US20100016221 Method of degrading protein by chaperone-mediated autophagy |
| 01/21/2010 | US20100016220 for diagnosis of a colorectal cell proliferative disease; treatment of gastric cancer or colorectal cancer |
| 01/21/2010 | US20100016217 Derivatisation of granulocyte colony-stimulating factor |
| 01/21/2010 | US20100016216 Adiponectin and uses thereof |
| 01/21/2010 | US20100016170 High throughput method for discovery of gene clusters |
| 01/21/2010 | US20100015725 Luminescent 1-hydroxy-2-pyridinone chelates of lanthanides |
| 01/21/2010 | US20100015723 Antagonists of Interleukin-15 |
| 01/21/2010 | US20100015703 Antibody to mammalian cytokine-like polypeptide-10 |
| 01/21/2010 | US20100015700 Use of the adenoviral e2 late promoter |
| 01/21/2010 | US20100015640 Nucleic Acid, Polypeptide and Its Use |
| 01/21/2010 | US20100015603 Chimeric proteins for measuring atp concentrations in pericellular space and related screening method |
| 01/21/2010 | US20100015600 Method for diagnosing and treating crohn's disease |
| 01/21/2010 | US20100015319 Precise breeding - low acrylamide foods |
| 01/21/2010 | US20100015215 Use of Glycolipids as Adjuvants |
| 01/21/2010 | US20100015197 Amphiphilic peptides and hydrogel matrices thereof for bone repair |
| 01/21/2010 | US20100015176 Settings for recombinant adenoviral-based vaccines |
| 01/21/2010 | US20100015173 Coiled-coil lipopeptide helical bundles and synthetic virus-like particles |
| 01/21/2010 | US20100015171 Vaccines comprising tb 10.4 |
| 01/21/2010 | US20100015170 Flagellin mutant vaccine |
| 01/21/2010 | US20100015168 Immunogenic compositions for streptococcus agalactiae |
| 01/21/2010 | US20100015163 Dendritic cell potentiation |
| 01/21/2010 | US20100015154 Immunogenic memapsin 2 b-secretase peptides and methods of use |
| 01/21/2010 | US20100015153 Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells and Antibodies That Identify the Same |
| 01/21/2010 | US20100015151 Polypeptides from neisseria meningitidis |
| 01/21/2010 | US20100015138 Crystal structure of Staphylococcus aureus clumping factor a in complex with fibrinogen derived peptide and uses thereof |
| 01/21/2010 | US20100015136 Camptothecin-peptide conjugates and pharmaceutical compositions containing the same |
| 01/21/2010 | US20100015124 Modulation of epidermal growth factor heterodimer activity |
| 01/21/2010 | US20100015117 Compositions and methods for targeting a polypeptide to the central nervous system |
| 01/21/2010 | US20100015113 Gp100-specific t cell receptors and related materials and methods of use |
| 01/21/2010 | US20100015108 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
| 01/21/2010 | US20100015096 Fusion Proteins of Mycobacterium Tuberculosis |
| 01/21/2010 | US20100015089 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 01/21/2010 | US20100015087 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 01/21/2010 | US20100015070 Use of natural, recombinant and synthetic resilins in cosmetics |
| 01/21/2010 | US20100015056 Uranium-chelating peptides and uses thereof |
| 01/21/2010 | US20100015043 Cytochrome c acetylation |